Coexpression of PPE 34.9 Antigen of Mycobacterium avium subsp. Paratuberculosis with Murine Interferon Gamma in HeLa Cell Line and Study of Their Immunogenicity in Murine Model by Deb, Rajib & Goswami, P. P.
SAGE-HindawiAccess to Research
Biotechnology Research International
Volume 2011, Article ID 632705, 10 pages
doi:10.4061/2011/632705
Research Article
Coexpression of PPE 34.9Antigenof Mycobacteriumavium
subsp.Paratuberculosis withMurine InterferonGamma inHeLa
CellLineand StudyofTheir Immunogenicityin MurineModel
RajibDeb and P.P. Goswami
Division of Animal Biotechnology, Gene Expression Laboratory, Indian Veterinary Research Institute, Izatnagar, UP 243122, India
Correspondence should be addressed to Rajib Deb, drrajibdeb@gmail.com
Received 28 May 2010; Revised 15 October 2010; Accepted 2 December 2010
Academic Editor: Udo Conrad
Copyright © 2011 R. Deb and P. P. Goswami. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
Mycobacterium avium subsp. paratuberculosis (Map) is the causative agent of johne’s disease whose immunopathology mainly
depends on cell mediated immuneresponse. Genome sequencing revealed various PPE (Proline-Proline-Glutamic acid) protein
familyofMapwhich are immunologicallyimportance candidate genes In present study we have developed a bicistrionic construct
pIRPPE/IFNcontaininga34.9kDaPPEprotein (PPE34.9)ofMapalongwithacytokinegeneencodingmurinegammaInterferon
gene(IFNγ) and a monocistrionicconstruct pIR PPEusinga mammalianvector system pIRES 6.1.The construct were transfected
in HeLa cell line and expression were studied by Western blot as well as Immuneﬂuroscent assay using recombinant sera. Further
we have compared the immunereactivity of these two constructs in murine model by means of DTH study, LTT, NO assay and
ELISA. DTH response was higher in pIR PPE/IFN than pIR PPE group of mice, similar ﬁnding also observed in case of LTT and
NO production assay . ELISA titer of the pIR PPE/IFN was less than that with PPE only. These preliminary ﬁnding can revealed a
CMI response of this PPE protein of Map and IFNγ having synergistic eﬀect on this PPE protein to elicit a T cell based immunity
in mice.
1.Introduction
Mycobacterium avium subsp. paratuberculosisis (MAP) is an
intracellular pathogen, the causative organism of Johne’s
disease (paratuberculosis), a debilitating chronic enteritis
in ruminants and has been implicated in Crohn’s disease
in humans characterised by hepatic granulomas in HIV-
negative,nonimmunosuppressed patients[1].Thispathogen
canmultiplyinside mononuclearphagocytesduetopresence
of various virulence determinants on their surface [2], and it
is evident that cell-mediated immune response controls the
resulting pathology.
The name PPE is derived from the motifs Pro-Pro-Glu,
found in conserved domains near the N termini of these
proteins having 180 amino acid sequences [3]. PPE proteins
are thought to be expressed on the cell surface [4, 5]a n d
have been found to be immunodominant antigens [6]. Some
of the PPE proteins of Mycobacterium species have been
reported to be potent T cell and or B cell antigens [7–14].
Although studies on various secretory proteins of
mycobacterial species have shown that they are potential
immunogens and can be used as subunit vaccine, using
eﬃcient immune adjuvants can enhance the performance
of the DNA vaccine. Various cytokines especially IFNγ,
IL-2, IL-6, IL-12, and IL-1 play a key role in immunity
againstmycobacterialinfections[15]andhavebeenshownto
increase the protectivitywhile used forcoimmunizationwith
DNA vaccines. The essential task of IFNγ in the resistence
of mice to mycobacterial infections has been make clear by
reports that knockout of IFNγ gene from the mice cannot
control or inhibit diﬀerent mycobacterial infections [16].
Recently,arecombinantPPEprotein,Map41,whichhasbeen2 Biotechnology Research International
reported as one of the IFN-γ-inducing antigens of MAP, also
strongly induced IL-10 from macrophages obtained from
infected calves [14].
BicistronicvectorshavebeenusedtodesignDNAvaccine
against HIV infection, which contained gp120 and GM-CSF
gene [17], bicistronic DNA vaccine containing apical mem-
brane antigen 1 and merozoite surface protein 4/5 can
prime humoral and cellular immune responses and partially
protect mice against virulent plasmodium chabaudi adami
DS malaria [18], and a bicistronic woodchuck hepatitis
virus core and gamma interferon DNA vaccine can protect
from hepatitis [19]. Recently from our laboratory, Kadam
et al. [20], have reported that coexpression of IFNγ with a
16.8kDagene of MAPcan enhance immunogenicity of DNA
v a c c i n eu s i n gt h es a m ep r o t e i n .I nt h ep r e s e n ts t u d y ,w eh a v e
used a similar approach to clone a 34.9kDa PPE (PPE34.9)
antigen of MAP in the A frame of the bicistronic vector
pIRES 6.1 having IFNγ gene in the frame B used by Kadam
et al. [20]. Further, we have studied the coexpression of these
two antigens in HeLa cell line. We have also preliminary
attempted to elucidate the immunogenic eﬀect of PPE 34.9
antigen of MAP on murine model and the role of IFNγ’s
adjuvant properties.
2.Materialsand Methods
2.1. Mycobacterial Strains. Solid and liquid cultures of MAP
316F were obtained from Central Diengenees Kunding Tieh
Institute, Lelystad, the Netherlands and maintained at Bio-
logical Products Division of IVRI, Izatnagar, and later main-
tained at Gene Expression Laboratory, Division of Animal
Biotechnology, IVRI, Izatnagar.
2.2. Plasmid Vectors and Host Strain Used. pTZ57R/T Clon-
ing vector and host strain DH5α of E. coli were supplied by
MBI Fermentas, Germany. Bicistronic vector pIRES 6.1 was
supplied from Clontech, USA.
2.3.LaboratoryAnimals. Swiss albinomice andNewZealand
white rabbits were obtained from Laboratory Animal Re-
source Section, IVRI, Izatnagar. Standard prescribed guide-
lines for care and use of laboratory animals were followed
during the experimentation with these animals.
2.4. Culture and Growth of MAP. MAP organisms were
grown on Middlebrook 7H10 agar enriched with 0.1% glyc-
erol v/v and 10% OADC with additional supplementation of
Mycobactin J (2mg/L) and were maintained at 37◦C.
2.5. Isolation of Genomic DNA Form MAP. The genomic
DNA from MAP was isolated by following the published
method [21].
2.6. Oligonucleotide Primers. A set of primers were designed
for the speciﬁc ampliﬁcation of the 1080bp PPE34.9 gene of
MAP based on the sequence information of MAP str.k10,
complete genome Gene Bank Accession no. AE016958.
Similarly, one set of primers was designed for the ampliﬁ-
cation of murine interferon gamma gene based on sequence
information (Gene bank Accession no. NM 008337). The
primers were synthesized by Integrated DNA Technologies,
USA. The nucleotide sequences of these primers were as
follows (Table 1).
2.7. Polymerase Chain Reaction and Ampliﬁcation of PPE34.9
Gene Fragment. Speciﬁc ampliﬁcation of the PPE gene from
the genomic DNA of M. a. paratuberculosis was carried
out using the above-mentioned primers pIRES MAP PPE
F and pIRES MAP PPE R. The PCR was carried out in
25μL reaction volumeusing 1μLo fg e n o m i cD N A( 1 0n g )a s
template, 2.5μLo fP C Rb u ﬀer,1μLo fM g C l 2 (1.5mM), 1μL
(25μM) of each primers, 1μL of dNTP mix (200μMo fe a c h
dNTP), and 1U of Taq DNA polymerase. The volume was
made up to 25μL by adding DNase-free water. The thermal
cycling steps were carried out in PTC-200 thermocycler MJ
Research Inc., USA with initial denaturation at 94◦Cf o r5
min followed by 30 cycles with denaturation at 94◦Cf o r
1 min, annealing at 55.0◦C for 1min, extension at 72◦C
for 30 seconds, and ﬁnal extension at 72◦Cf o r1 0 m i n .
Size of the ampliﬁed product was conﬁrmed by using DNA
molecular weight marker in a 1% agarose gel and quantiﬁed
by spectrophotometric analysis.
2.8. Cloning of PPE34.9 Gene of MAP in pTZ57R/T Cloning
Vector. 2μL (100ng) of eluted PCR product, 1μLo f
pTZ57R/T(55ng),2μLof5Xligationbuﬀer,1μLofT4DN A
ligase (5 units) were mixed in a sterile microcentrifuge tube
and the volume was made up to 10 μLw i t hn u c l e a s ef r e e
water. The ligation mixture was kept at 22◦Co v e r n i g h ta n d
storedat −20◦C.CompetentE.coliDH5αcellswereprepared
and transformed with 10μL of ligation mixture as stated
above. The transformed cells were spread on LB agar plate
containing ampicillin (100μg/mL), X-GAL (25μg/mL) and
IPTG(25μg/mL).Appropriatepositiveand negative controls
were processed simultaneously. Plates were incubated at
37◦C overnight and later stored at 4◦C. Ten white colonies
were picked up and grown in LB broth containing ampicillin
and incubated at 37◦C overnight in a shaker incubator at
180rpm. Plasmid DNA was extracted by miniprep plasmid
isolation method [22]. Identiﬁcation of positive colonies was
done by Colony PCR and subsequently conﬁrmed by RE
analysis and designated as pTZ PPE.
2.9. Cloning of PPE Gene of MAP in a Mammalian Bicistronic
Expression Vector pIRES and Plasmid Construct pIR IFN.
The insert from the positive clone pTZ PPE (containing
the appropriate restriction sites NheIa n dEcoRIs p e c i ﬁ cf o r
frame A of pIRES vector) was released by digesting with the
enzymes Nhe Ia n dEcoRI. The digested product was then
ligated in the frame A after digestion of the vector with Nhe I
and EcoRI to prepare monocistronic construct pIR PPE. The
ligation mixture was transformed in E. coli competent DH5α
cells. Further, to prepare bicistronic construct pIR PPE/IFN,
pIR IFN [20] was used and same strategy was adapted to
insert the PPE 34.9 in the frame A.Biotechnology Research International 3
Table 1: List of speciﬁc primers used for the present study.
Primers Oligonucleotide sequences
pIRES MPPPE
F(Sense)
5 
GCCGCTAGCATGTGGGTCCAGGCCGCCAC
3 -29 mers
pIRES MPPPE
R(Anti sense)
5  GCCGAATTCTTACTCGGTTCCAGCGTTGC
3 -29 mers
IFN
F(Sense)
5  GCCTCTAGAATGAACGCTACACACTGC
3 -27 mers
IFN
F(Anti sense)
5  CCGCGGCCGCTCAGCAGCGACTCCTTTT
3 -28 mers
2.10. Preparation of Transfection Grade Plasmid. Large scale
puriﬁcation of the plasmid constructs pIR PPE and pIR
PPE/IFN was done using endotoxin-free QIAGEN mega kit
according to the manufacturer’s instructions (Qiagen, Inc.,
Valencia, California).
2.11. Transfection of Plasmid Constructs in HeLa Cell line.
The puriﬁed recombinant plasmids pIR PPE and pIR
PPE/IFN were transfected to 60–70% conﬂuent HeLa cells
using SuperFect transfection reagent kit, following manu-
facturer’s instructions (QIAGEN, Germany). Brieﬂy, HeLa
cell monolayer was subcultured and the cells were seeded
in 25cm2 tissue culture ﬂask. When 60–70% monolayer
was achieved, the cells were used for transfection. 5μgo f
each DNA in 20μL TE (pH 7.5) was diluted separately in
optiMEM. Then 30μL of superfect transfection reagent was
added to the DNA solution. Afterwards, growth medium
was aspirated from the dish and cells were washed with
two mL DMEM (without serum and antibiotic). Then,
0.8mL of the same DMEM were added to the reaction tube
containing the transfection complexes and mixed properly.
The mixtures thus prepared were layered separately over the
cells and incubated for 6hrs at 37◦C followed by addition
of DMEM with 10% FCS, and incubation was continued
in a humidiﬁed CO2 incubator. Cells transfected with the
respective plasmid constructs were harvested after 72hrs
of incubation by adding about 80μL of 2X SDS-PAGE
loading buﬀer, and the expressed proteins were resolved on
SDSPAGE and western blotting using hyperimmune sera
raisedinrabbitagainst recombinantPPE34.9protein(1:200
in PBS).
2.12. RT-PCR (Reverse Transcription Polymerase Chain Reac-
tion) for Conformation of Expression of IFN. One mL of
trizol was layered on the transfected monolayer and the
cells were lysed. Total RNA was isolated from the cells
and ampliﬁed by RT-PCR. The ampliﬁed product was
checked on 1.5% agarose. One mL trizol was added on
the transfected monolayer and homogenized by passing the
lysate10timesthroughasterile20Gneedleﬁttedtoasyringe
and transferred to a sterile 1.5mL eppendorf. Further, the
sample was kept at room temperature for ﬁve minutes.
200μL of chloroform was added to the sample and mixed by
vortexing.Itwasallowedtostandatroomtemperaturefor10
minutes. The sample was then centrifuged at 12000rpm for
20 minutes. The aqueous phase was collected in a separate
vial to which 500μL of isopropanol was added, mixed gently,
and kept at room temperature. RNA pallet was washed with
500μL70%ethanolanddissolvedinnuclease-free water.The
yield of total RNA was determined spectrophotometrically
using the formula
OD26O × 33 × 200 × 10
−3 = μg/μL. (1)
RT-PCR was carried out using RT PCR kit (MBI Fermentas,
Germany). In a sterile microfuge tube, 2μgo ft o t a lR N A
from pIR PPE/IFNwere carried outto which 1μLo fra n d o m
hexamer primer was added and incubated at 70◦Cf o r5m i n .
Then, mixture, 1μLR N a s ei n h i b i t o r ,2μL of DNTP, and 4μL
of 5x RT buﬀer were added and tube was incubated at 37◦C
for 5min. Thereafter, 1μL of m MLV reverse transcriptase
was added and the volume was made up to 20μL by adding
nuclease free water. The sample was incubated at 42◦Cf o r
1hr, followed by incubation at 72◦Cf o r1 0m i n .T h ec D N A
was stored at −20◦C, until used. Ampliﬁcation of IFNγ
speciﬁc fragment from the cDNA preparation was prepared
containing 4μL of the cDNA sample, 2.5μL of 10x PCR
buﬀer, 200μM of each Dntp, and 50pMol each primers
IFNpIR F and IFNpIR R. IFNγ ampliﬁcation mixture
was subjected to 30 cycles of denaturation (94◦C, 1min),
annealing (55◦C, 45sec), and extension (72◦C, 1min) with
a further ﬁnal cycle for primer extension (72◦C, 5min).
2.13. Indirect Immunoﬂuorescence Assay (IFA). HeLa cells
were seeded in 24 well plates and when a 60–70% conﬂuent
monolayer was achieved, two wells each were transfected
with pIR PPE, pIR PPE/IFN, and pIRES (mock) plasmid.
After incubation for 72hr the medium was aspirated from all
the wells, and the cells were permeabilized by adding 250μL
of 80% acetone for 30min. Then, acetone was aspirated and
the plate was dried at RT for 1hr. Blocking was done using
1% BSA for 2h at 37◦C. Primary antibody (hyperimmune
sera) was addedat 1:50dilution and keptforone hr at 37◦C.
This was followed by three gentle washes with PBS. FITC-
labeledantirabbitconjugatewasaddedat1:200dilutionand
kept for 1hr at 37◦C followed by washing with PBS and
mounted in 50% PBS-glycerol. Cells were examined under
ﬂuorescent microscope.
2.14. Immunization of Animals with Plasmid Constructs.
Swiss albino mice supplied by Laboratory Animal Section,
IVRI,Izatnagar weremaintained onrationcomprisingwheat
dalia 62%, maize 30%, wheat bran 7%, salt 1%, and mineral
mixture 25ppm with 5mL milk per mouse. The animals
were divided into four groups, namely, A, B, C, and D each
containing ten mice. They were vaccinated with the puriﬁed
recombinant plasmid as shown in the Table 2.
Mice (three numbers) from each group were bled on the
21st and the 42nd days for serum separation which were
stored at −20◦C and used in the determination of antibody
titres by ELISA.
2.15.Collection ofMacrophagesand Splenocytesfrom Plasmid-
Immunized mice. On the 42nd day after immunization of
mice, four mice from each group were selected randomly.4 Biotechnology Research International
Table 2: Mice Immunizationschedules.
S.
no.
Mice
group
Plasmidconstruct
used
First dose
(0 day)
Booster dose
(35th day)
1A T E b u ﬀer control 100μg 100μg
2 B pIRES mock control 100μg 100μg
3 C pIRESPPE 100μg 100μg
4 D pIRESPPE /IFN 100μg 100μg
About 5mL of sterile RPMI 1640 medium were injected
into the peritoneal cavity of each mouse, gently massaged,
and the mice were left in the cage for 5min. Then, the
mice were sacriﬁced by CO2 asphyxiation, and the peritoneal
ﬂuid was aspirated. The macrophages in the aspirated ﬂuid
were collected by centrifugation and resuspension of the
obtained pellet in RPMI 1640 medium and subsequently
used for nitric oxide (NO) estimation. After aspiration of
peritonealﬂuid,abdominalcavitywascutopen.Spleenswere
harvested from sacriﬁced mice and made into a single cell
suspension. The cells suspended in RPMI-1640 were layered
over Ficoll-Paque PLUS, and mononuclear splenocytes were
isolated by density gradient centrifugation at 1350 × gf o r3 0
min. Splenocytes thus obtained were used for LTT and RNA
isolation.
2.16. Measurement of DTH Reaction. Six mice from each
group were selected for DTH study. On the 42nd day after
ﬁrst immunization. All the mice were injected intradermally
with 10μg of johnin in right hind foot pad and 10μg ofpuri-
ﬁed PPE 34.9 recombinant protein in the left hind foot pad.
The results of the local skin reactions (DTH) were observed
after 48h by measuring the two transverse diameters of
erythemausingVerniercaliperswithaminimummeasurable
increment of 0.01mm. Data was statistically analyzed using
Students’t-test at a signiﬁcant level of P<. 05.
2.17. Lymphocyte Transformation Test (LTT). The mononu-
clearsplenocytes(5 × 105 cellsper well) from fourmice were
placed in 96 well plates (Nunc, Denmark) in complete
RPMI-1640 (phenol red free) medium containing 10% heat-
inactivated foetal calf serum, 2mM L-glutamine, 100U of
penicillin, and 100mg streptomycin per ml. Respective Ni
NTA column-puriﬁed recombinant PPE 34.9 [23] and ConA
(positive control) were added at the ﬁnal concentration of
40μg/mL and 10μg/ml, respectively. RPMI was used as the
negative control. The total volume per well was 200μL. The
plates were kept in a humidiﬁed CO2 incubator at 37◦C
for 72h. At the end of the incubation, 20μL of the yellow
tetrazolium salt MTT (5mg/mL) were added and incubated
at 37◦C for 4h. In the presence of living cells, MTT is
transformed to purple formazan [24]. Subsequently, 100μL
of 0.04N HCl in isopropanol were added and allowed to
react for 30min to stop the colourdevelopmentreaction and
dissolve the formazan crystals. The absorbance (OD) of the
samples was measured in an ELISA reader at 570nm (and
650nm as reference) wavelength. Assays were conducted
in triplicates, and the results expressed as Mean ± SE.
Stimulation index (SI) was calculated using the formula
M 1 1234567 M2
21226bp
5148bp
2027bp 1444bp
943bp
754bp
585bp
458bp
341bp
258bp
Figure 1: Agarose gel electrophoresis (1%) of the cloned fragment
of the gene encoding PPE protein in pIRES IFN PPE mam-
malian vector. Lane M1: DNA molecular weight marker Lamda
DNA/EcoRI/Hind III. Lane1: pIRES IFN PPElinearisedwith EcoRI.
Lane 2: released insert of 1080 bp after NheIa n dEcoRI digestion of
recombinant pIRES IFN PPE recombinant plasmid DNA. Lane 3:
PCR ampliﬁed fragment encoding PPE protein of Mycobacterium
avium subsp. paratuberculosis. Lane 4: pIR IFN linearised with Xba
I. Lane 5: release IFN fragment (467 bp) by digestion with Xba I
and Not I from pIR IFN vector DNA. Lane 6: release IFN fragment
(467bp) bydigestionwithXba IandNot IfrompIR IFNPPEvector
DNA. Lane 7: PCR ampliﬁed fragment of IFN (467 bp). Lane M2:
DNA molecular weight marker pUC18/Sau3AI-pUC18/TaqId i g e s t .
SI = ODofstimulatedculture ÷ODofunstimulatedculture.
SI value of >1.2 (i.e., 33% more than the control) was
considered for lymphocyte proliferation. Data was analysed
for signiﬁcance between mock pIR and pIR PPE as well as
pIRPPE and pIRPPE/IFNconstructsby Student’st-test,and
diﬀerences with P<. 05 were considered within the level of
signiﬁcant.
2.18. NO Production Assay. The RPMI 1640 complete me-
dium was supplemented with 5mM of L-arginine for this
assay. 100μL of the cell suspension containing 2 × 105
peritoneal macrophages from four mice from each group
were plated in triplicate in 96 well plates. Respective antigen
Ni NTA column-puriﬁed recombinant PPE 34.9 [23]a n d
LPS (positive control) in RPMI 1640 medium (100μL)
were added at the ﬁnal concentration of 40μg/mL and
2μg/mL,respectively. RPMIwasused asthenegative control.
The total volume per well was 200μL. The plates were
incubated at 37◦Ci nah u m i d i ﬁ e dC O 2 (5%) incubator
for 48h. Supernatants were collected from all the wells and
stored at −20◦C until NO estimation. For NO estimation
NaNO2 (sodiumnitrite)in diﬀerentconcentrationswasused
as standard. In a 96-well ELISA plate to 50μlo ft h ec e l l
culture supernatant or standard, 60μL of Griess reagent (1%
sulfanilamide in 1.2 N HCl) (Sigma) was added, and the
plates were incubated at 37◦C for 30min, A550 reading wasBiotechnology Research International 5
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Figure 2: Western blot assay of 72-hour culture of HeLa cell trans-
fected with pIRPPE and pIRPPE/IFN showing expressed 34.9kDa
PPE protein. Lane M: prestained protein molecular weight marker.
Lane 1: whole cell lysate of HeLa cell transfected with pIRES (mock
control). Lane 2: whole cell lysate of HeLa cell transfected with
pIRES PPE. Lane 3: whole cell lysate of HeLa cell transfected with
pIRES PPE/IFN.
taken on a microplate ELISA reader. By using the standard
curve (NaNO2 concentration versus A550) the NO levels in
thesampleswereestimated.DatawasanalysedbyStudent’st-
test,and diﬀerenceswith P<. 05were considered signiﬁcant.
2.19. Characterization of PPE Speciﬁc Antibodies in Mice
Groups Immunized with Plasmid Constructs by ELISA. The
optimum concentration of Ni NTA column-puriﬁed recom-
binant PPE 34.9[23] antigen and conjugate were determined
using block titration as described by Engwal and Pearlman
[25]. The wells of ELISA plates (Nunc, Denmark) were
coated with 200ng/well of antigen diluted in carbonate
bicarbonate buﬀer, and the plates were incubated at 4◦C
overnight. The plates were washed thrice with PBS-Tween
20 (PBS-T) and blocked with 5% skim milk powder in PBS-
Tf o r2ha t3 7 ◦C. Then, 1:200 dilution of serum in 100μL
volume of PBS-T were added in duplicate and incubated
at 37◦C for one hour. The plates were washed thrice with
PBS-T for 3min at each wash. Conjugate antimouse IgG
HRPO at dilution of 1:10,000 in 100μL volume was added
to each well, and the plates were incubated for 1hr at 37◦C.
The plates were then washed three times with PBS-T, and
colour was developed with 100μLo f1 0m g / m LO P Dw i t h
10μL of30%H2O2 insubstrate buﬀer.Aftersuﬃcientcolour
development, the reaction was stopped by the addition of
50μL1 NH 2SO4, and the plates were read at 490nm in an
ELISA reader (Tecan, Austria).
3.Results
3.1. Construction and Characterization of Plasmids pIR PPE
andpIRPPE/IFN. Thebicistronicconstructsweregenerated
after cloning PPE34.9 gene fragment from Nhe Ia n dEco
RI digested PCR product into frame A of Nhe Ia n dEco
RI digested plasmid vector and Xba I- Not Id i g e s t e dI F N γ
into frame B of the same vector. The positive colonies
from the construct was identiﬁed by obtaining desired size
products using colony PCR and subsequently conﬁrmed by
the release of identical size inserts on RE analysis (Figure 1).
Table 3: DTH responses in mice immunized with plasmid con-
structs expressed as mean diﬀerences (mm) upon recall with 10
microgram of PPE34.9.
Groups PBS PPE 34.9
Group A (TE buﬀer as control) 0.082 ± 0.001 0.235 ± 0.018
Group B pIRES (mock) 0.082 ± 0.0007 0.111 ± 0.011
Group C pIRES PPE 0.211 ± 0.007 2.516 ± 0.132
Group D pIRES PPE 0.215 ± 0.0104 3.115 ± 0.005
The plasmid constructs (monocistronic and bicistronic)
were transfected into 60–70% conﬂuent HeLa cell line, and
the expressed PPE34.9 protein was detected from 72-hour
posttransfected cell lysate in western blot using polyclonal
serum raised in rabbit against recombinant PPE34.9. No
such band was observed in cell lysate transfected with mock
plasmid (Figure 2). The 72-hour posttransfected HeLa cells
with plasmid constructs pIR PPE and pIR PPE/IFN on IFA
using FITC-labeled conjugate exhibited ﬂuorescence under
ﬂuorescent microscope, indicating the expression of the
PPE34.9 protein (Figures 3(a), 3(b), 3(c),a n d3(d)).The
monoclonal antibodies against murine IFNγ could bind
with HeLa cell expressed IFN protein to reconﬁrm IFNγ
expression from the construct pIRPPE/IFN, RT-PCR was
done for the cDNA obtained from total RNA of a 72-hour
posttransfected HeLa cell lysate using speciﬁc primers of
murine IFNγ.A t5 5 ◦C, annealing temperature gave the
ampliﬁed product of 467bp (Figure 4).
3.2. Induction of DTH Response. DTH response was mea-
sured with Vernier Calipers 72 hrs after injection of PPE34.9
protein in the foot pad of Plasmid-immunized groups of
mice. Skin reactions to recombinant PPE34.9 protein was
studied. Both the control groups showed no signiﬁcant
reaction to antigen. Mice group immunized with pIR PPE
and pIR PPE/IFN evoked visible skin reactions in the
form of necrosis and erythema. However, more signiﬁcant
(3.115 ± 0.005) erythematous lesions were observed in mice
immunized with pIR PPE/IFN in comparison to pIR PPE-
immunized groups (2.516 ± 0.132). Whereas, mice immu-
nized with plasmid pIRES (mock) showed no signiﬁcant
swelling when compared to the injection of PBS (Table 3).
Statistical analysis with Student’s t-test showed signiﬁcant
diﬀerence (P<. 05) between pIR PPE/IFN and pIR PPE
alone.
3.3. LTT-Based In Vitro Lymphocyte Proliferation Test. The
puriﬁed recombinant PPE34.9 protein stimulated a signif-
icant proliferation of mononuclear splenocytes from mice
groups immunized with constructs pIR PPE and pIR PPE/
IFN. Higher proliferation was obtained with construct pIR
PPE/IFN (1.38 ± 0.079) followed by group pIR PPE (1.21 ±
0.076) upon stimulation with puriﬁed PPE34.9 protein.
(Table 4). Statistical analysis with student’s t-test showed
signiﬁcant diﬀerence (P<. 05) between pIR (mock) and pIR
PPE as well as pIR PPE and pIR PPE/IFN groups.
3.4. NO Production Assay. Peritoneal macrophages collected
fromvariousmicegroupswerestimulatedwiththerespective6 Biotechnology Research International
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Figure 3: (a) Healthy HeLa cells (untransfected). (b) HeLa cells transfected with pIRES mock control. (c) HeLa cells transfected with pIRES
PPE vector construct showing expression of PPE protein using o polyclonal sera raised in rabbit against PPE 34.9 react with FITC-labeled
antirabbit conjugate. (d) HeLa cells transfected with pIRES PPE/IFN vector construct showingexpression of PPE protein using o polyclonal
sera raised in rabbit against PPE 34.9 react with FITC-labeled antirabbit conjugate.
Table 4: Lymphocyte transformation test for mice groups immu-
nized with Plasmidconstructs (SI = Mean ± SEM).
Groups ConA PPE protein
A( T Eb u ﬀer control) 1.03 ± 0.05 0.96 ± 0.042
B (pIRES mock control) 1.04 ± 0116 0.97 ± 0.031
C (pIRESPPE) 1.3 ± 0.101 1.21 ± 0.076
D (pIRESPPE /IFN) 1.41± 0.17 1.38 ± 0.079
antigens to measure the amount of nitric oxide produced
by the cells. The quantity of NO produced was estimated
by comparing with known standards of sodium nitrite. LPS
induced signiﬁcant production of NO in all the groups.
Among the immunized groups, NO production was found
highest in group pIR PPE/IFN (Mean ± SEM = 38.62 ±
1.02μm/2 × 105 cells) followed by group pIR PPE (Mean ±
SEM = 26.19 ± 0.53μm/2 × 105 cells) uponstimulation with
recombinant PPE34.9 protein. (Table 5). Statistical analysis
with student’s t-test showed signiﬁcant diﬀerence (P<. 05)
betweenpIR(mock)and pIRPPE aswell aspIRPPEand pIR
PPE/IFN groups.
3.5. Detection of Immune Response Induced by Various Plas-
mids Constructs in Mice by ELISA. To evaluate the humoral
immune response induced by plasmid constructs in mice
Table 5: Nitric oxide production assay of peritoneal macrophages
from mice groups immunized with Plasmid constructs (μmo f
NO/2 × 105 cells = Mean ± SEM).
Groups LPS PPE protein
A(T Eb u ﬀer control) 29.32 ± 0.5042 7.85 ± 0.2933
B (pIRES mock control) 30.77 ± 0.6617 7.29 ± 0.3199
C (pIRESPPE) 33.43 ± 1.9381 26.19 ± 0.535
D (pIRESPPE /IFN) 40.89 ± 2.3452 38.62 ± 1.020
groups, on the 21st day and the 42nd day postimmunization
antibody titres were determined by indirect ELISA.Antibod-
ies were detected in all the plasmid constructs immunized
groups of mice (OD490 > 0.3 in the serum dilution range
of 1:200). Whereas, insigniﬁcant titres were observed in
control groups (Table 6).
4.Discussion
Presently, chemotherapy is unrewarding and economically
not feasible to control the diseases. Eﬀective control pro-
grammes for the disease are hampered due to lack of speciﬁc
diagnostic tests to detect infection in the early stages of
disease. Further the currently available immunodiagnostic
tests have limited sensitivity [26]a n ds p e c i ﬁ c i t y[ 27].Biotechnology Research International 7
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Figure 4: Agarose gel electrophoresis (1.5%) showing RT-PCR
based expression of IFNγ ORF in pIR PPE IFN transfected HeLa
cells. Lane M: prestained protein molecular weight marker (100 bp
ladder). Lane 1: negative control mock plasmid transfected HeLa
c e l l s .L a n e2 :I F N γ encoding gene from pIR PPE IFN transfected
HeLa cells with super natantγ. Lane 3: positive control (IFNγ)
encoding gene from ConA induced mice splenocytes.
Table 6: ELISA titres of plasmid construct-injected mice groups
(OD490 = Mean ± SEM).
Groups 21st day 42nd day
Blank 0.031 ± 0.0035 0.044 ± 0.0034
A( T Eb u ﬀer control) 0.131 ± 0.0076 0.136 ± 0.012
B (pIRES mock control) 0.142 ± 0.0371 0.156 ± 0.012
C (pIRESPPE) 0.312 ± 0.0204 0.322 ± 0.030
D (pIRESPPE /IFN) 0.263 ± 0.018 0.283 ± 0.021
Conventional live attenuated vaccines are not completely
protective [28, 29]. Studies have shown that CMI develops
in early stages for clearing infection [30] whereas high
serum antibody concentration is often seen in advanced
clinical cases [31]. The cell-mediated immunity plays a
pivotal role to control the spread of organisms within the
host body [32]. DNA vaccines may open new horizons for
eﬀective vaccination against paratuberculosis as strong CMI
responses includingCTLand Th1 typecytokinesare induced
[20].
Expressions of T cell antigens in prokaryotic vector
have failed to induce CTL and cytokine response. However,
expression of T cell antigen in a mammalian vector for
eliciting CD4+ T cell response and CD8+ cytotoxic T cell
response to generate immunity have been reported in a
number of animal models [33–36]. Cytokines also (mainly
IFNγ,T N F α, IL10 etc.) play a major role in the protective
immune response against mycobacterial diseases [14, 32].
Coexpression of T cell antigen with costimulatory molecules
in a bicistronic eukaryotic system made the DNA vaccine
more eﬀective [17–20]. Moreover, expression of two T cell
antigens in eukaryotic bicistronic system may also be useful
for enhancing protective immunity.
After the completion of the genome sequencing of MAP,
the PPE protein family has been widely assumed to represent
immunologically important antigens of the mycobacterial
species. The present work envisaged keeping in view the
role of a PPE antigen and the concept of bicistronic DNA
constructs using an immunostimulatory molecule IFNγ is
likely to potentiate immune response in mice. The use
of cytokines as adjuvant is known to enhance immune
responses when they were administered during the devel-
opment of immune response against a particular antigen
[37, 38]. IFNγ is the most extensively studied cytokine in
mycobacterial infections. It is the deﬁning cytokine of Th1
subset and activates macrophages for microbicidal activity. It
induces IL12, which causes Th cells to diﬀerentiate into Th1
subset [39].
Inthepresentstudy,thegenefragmentencodingPPE34.9
protein was cloned into the frame A of the bicistronic
vector pIRES6.1 containing IFNγ gene in frame B and also
a monocistronic plasmid construct pIR PPE was made. The
constructs were designated as pIR PPE/IFN and pIR PPE,
respectively. Bicistronic vector pIRES6.1 contained immedi-
ate early CMV promoter for simultaneous expression of the
two genes downstream to it as active protein. Expression of
the PPE34.9 and IFNγ. (17 kDa) proteins was conﬁrmed
by western blot and immunoﬂuorescence assay in 72-hour
posttransfected HeLacelllysatesusingpolyclonalsera.Sizeof
mouse IFNγ.gene is 1208bp in length but coding sequence is
467bp,which wasused forIFNγ.ORFexpression. Theresults
were in agreement with the eukaryotic bicistronic expression
of16.8kDaantigenofMAPandmurineIFNγ.inabicistronic
vector [20], a glycoprotein C of pseudorabies virus [40]a n d
an apical membrane antigen and merozoite surface protein
of Plasmodium chabaudi DS malaria [18].
In the present study, we have cloned and coexpressed
a 34.9kDa protein-encoding PPE gene family antigen with
IFNγ gene in HeLa cell line. Further, we have studied the
immune responses of these plasmid constructs in mice.
Elucidation of DTH response against recombinant P35
proteins and 16.8kDa proteins of MAP has been studied
by and Basagoudanavar et al. [41]a n dK a d a me ta l .[ 20],
respectively. DTH-based immune response is an indicator of
T-cell-based immunity. We have already elucidated the DTH
response of puriﬁed recombinant PPE 34.9 proteinin mice
[23]. In the present study we have compare the eﬀect of IFN
as pIR PPE/IFN construct on PPE 34.9 as pIR PPE construct,
which showed that a signiﬁcant higher immune response of
theﬁrst constructonthesecondoneindicatetheroleofIFNγ
to elicit a T cell based immune response.
Cell proliferation as a test has been used to assess
DNA vaccines against mycobacterial infections [20, 41].
In the present study, mononuclear splenocytes from mice
group immunized with pIR PPE/IFN showed higher cell
proliferation than pIR PPE, which may indicate the eﬀect
of IFNγ. IL2 is known as the cytokine for cell proliferation,
but IFNγ indirectly induces cell proliferation by activating
macrophages and increasing antigen presentation which8 Biotechnology Research International
induces IL2 receptors on T cell surface, thereby inducing
cell proliferation. The results were in consensus as found
by other workers who used cytokines as immunoadjuvant
in bicistronic DNA vaccine. Chow et al. [42]h a v er e p o r t e d
increased cell proliferation in group that received hepatitis
B virus surface protein and IL2 as bicistronic DNA vaccine.
Barouch et al. [17] found twofold augmentation of cell
proliferation in bicistronic group which coexpressed gp120
gene of HIV and GMCSF than in monocistronic gp120
immunized group. Kadam et al. [20], also found that
bicistronic vector expressing a 16.8kDa protein of MAP
along with IFNγ gene induce higher proliferative response
than the protein alone.
It isknown that RNIr nitrogenintermediates), especially
nitric oxide (NO), are most eﬀective in direct killing of
mycobacteria [15]. An increased production of NO-induced
vaccine candidate genes may be one of the important
causes of eﬀective immune response against mycobacterial
infection. As in our present study, NO production from
cells of pIR PPE/IFN group was comparatively higher than
PPE34.9 alone, it may again indicate the role of IFNγ in the
induction/stimulation of macrophages to release RNI (NO).
Recombinant protein PPE 34.9 was puriﬁed using single-
step Nickel-NTA (pQE 30 UA containing His tag vector was
used) aﬃnity column chromatography [23], chance of LPS/
endotoxin contamination is negligible. The results were in
consensus as found by other workers who reported that it
plays an important role in release of NO from monocytes
[20, 43].
ELISA adopted to study the humoral immune response
following DNA vaccination in mice for 22kDa antigen of M.
bovis [44] and MPT64, Ag85B, and ESAT-6 [45]a n t i g e n s
of M. tuberculosis showed signiﬁcant increase in log titre of
circulating antibodies. In the present study, antibody titer of
the construct pIR PPE/IFN was less than that with PPE34.9
only. It may be possible that here IFN down regulating the
IgG mediate humoral immunity induced by PPE34.9 protein
which needs to be further conﬁrmed in large number of
animals. This result may be correlated to the groups who
ﬁnd that codelivery of IFN-gamma or IL-4 encoding EG95
protein of Echinococcus granulosus,t h ec a u s a t i v ea g e n to f
hydatid appeared to reduce the ability of the DNA vaccine
toprimeanIgGantibody response demonstratedtheeﬃcacy
ofthecodeliveryofcytokinestomodulateimmuneresponses
generated in a DNA prime-protein boost strategy [46].
Overall, the preliminary ﬁndings possibly revealed that
thePPE34.9antigen ofMAPmay be a T-cell-based immuno-
gen. This is in agreement with the studies reported on PE
antigen of M. avium by Parra et al. [47], antigen induced
both cell-mediated [48] and humoral immune responses
[49]which again wasincorroborationwith theearlierworks.
Immune adjuvants plays an important role to enhance
thepr ot ecti v eeﬃcacyofDNAvaccines[50]. IFNγ isa potent
activator of macrophages and is the keycytokinein Th1-type
immune response in paratuberculosis infection produced by
both CD4+ and CD8+ cells [20, 51]. Hence for the develop-
ment of an eﬀective measure against paratuberculosis, it is
necessary to apply those strategies that should enhance the
T cell mediate response. From our preliminary observations,
we have also noticed that the monocistronic construct pIR
PPE elicited a comparatively milder CMI response than
pIR PPE/IFN. This may revealed that the presence of IFNγ
synergized the T cell response of PPE34.9 protein.
These preliminary observations need further conﬁrma-
tion like in vitro study of the Th1 cytokine mediate response
of the PPE34.9 and challenge studies in experimental as
well as natural hosts for the development of an eﬀective
bicistronic DNA vaccine against paratuberculosis infection.
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